Canadian and global investors gain early access to Opus One, a luxury residential development in IndiaMISSISSAUGA, ON, June 2, 2026 /CNW/ - Captain Advisory...
World-Famous Plant-Based Burger Enters New Chapter of Growth With Experienced Operators Leading Expansion Efforts ATLANTA, June 2, 2026 /PRNewswire/ -- Slutty Vegan, the nationally...
Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...
Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...
PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced its inclusion in the Euronext Tech Leaders segment and Euronext Tech Leaders Index, a Euronext flagship initiative dedicated to increasing the visibility and attractiveness of Europe’s leading and high-growth technology companies among international investors.
KUALA LUMPUR, Malaysia, June 2, 2026 /PRNewswire/ -- TMGM has announced its return as the Presenter Sponsor for the upcoming Jay Chou concert in Malaysia,...
Established pavement striping company launches fresh franchise location in Charleston, offering property owners affordable striping options for worn out parking lots, sport courts, and...
First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile
PAPZIMEOS approval marks a historic milestone for the RRP patient community as the first and only FDA-approved therapy for the treatment of adults with...